Publications and reference
Back to Abstracts provided from 2006
Abstracts from July 2006
Read the abstracts from July 2006
- 263: Attenuated live vaccines
- 264: Study of growth, regeneration and metaplasia
- 265: Behavioural ecology of fish
- 266: Presynaptic mechanisms in control of nerve cell
- 267: Mechanisms of metastasis
- 268: Fish Reproduction and Ecotoxicology
- 269: The supply of Xenopus and genetically modified amphibians
- 270: Production of biological materials
- 271: Use of positron emission tomography to study cancer pathophysiology and the effects of novel therapies
- 272: Investigation of drug delivery systems
- 273: Genetically modified mice with developmental deficits
- 274: Biocompatibility of tissue engineering scaffolds
- 275: Nerve sprouting, corneal and skin wound healing
- 276: Studies on kinase modulators of cancer
- 277: Use of selected in vivo models for drug discovery
- 278: The genetics complex phenotypes/malaria parasites
- 279: Transplantation of mammalian stem cells
- 280: Scaffold devices for wound healing
- 281: Host pathogen interaction and responses to Salmonella
- 282: Environmental effects on energy balance regulation
- 283: Abstract in course of preparation
- 284: Remodelling of arteriovenous grafts in fibulin 5 knock out mice
- 285: Infections of the genital tract
- 286: Improving cancer therapy
- 287: Gene therapy for treating heart disease.
- 288: DNA damage and genetic predisposition to cancer
- 289: No abstract provided
- 290: Cell therapy for treating heart disease
- 291: Induction of mucosal immunity and oral tolerance
- 292: Adaptation to myocardial stress
- 293: Metabonomics of intestinal ischemic reperfusion injury in the rat.
- 294: Pathophysiology of diabetes
- 295: Egg production in Xenopus laevis
- 296: A European Xenopus stock centre
- 297: Host responses to cryptosporidium parvum infection
- 298: Inter-connected studies of prion and other neurodegenerative diseases
- 299: Tumour model development and therapeutic strategies
- 300: Mouse models of arteriosclerosis
- 301: Establishing safety and efficacy information on new drugs and vaccines for use within the agricultural I livestock industry
- 302: Investigating the role of angiogenesis
- 303: Mammalian gene control mechanisms and disease
- 304: Molecular imaging in cancer
- 305: Contract in vivo studies on compounds and vaccines
- 306: Modelling cancer predisposition by BRCA2 mutations
- 307: Development of new analgesic medicines
- 308: No abstract provided
- 309: Population and imunocompetent genetic variation
- 310: Immunobiology and vaccinology of Leishmania infections
